2nd Circ. OKs Quick Actavis Appeal In Namenda Antitrust Suit
The Second Circuit on Tuesday agreed to an expedited hearing on Actavis PLC's appeal of a preliminary injunction barring the drugmaker from halting sales of immediate-release dementia drug Namenda in the...To view the full article, register now.
Already a subscriber? Click here to view full article